Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suyu Shu

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II moleculesMaria R Parkhurst, Cormac DePan, John P Riley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
Memory T cells originate from adoptively transferred effectors and reconstituting host cells after sequential lymphodepletion and adoptive immunotherapyLi-Xin Wang, Jorgen Kjaergaard, Peter A Cohen, et al.
The Laryngoscope|May 3, 2006
Everolimus (RAD) inhibits in vivo growth of murine squamous cell carcinoma (SCC VII)Samir S Khariwala, Jorgen Kjaergaard, Robert Lorenz, et al.
Cancer Metastasis Reviews|June 14, 2006
Immune responses in the draining lymph nodes against cancer: implications for immunotherapySuyu Shu, Alistair J Cochran, Rong-Rong Huang, et al.
Head & Neck|November 13, 2009
Toll-like receptor agonists as third signals for dendritic cell-tumor fusion vaccinesEdward I Cho, Chunrui Tan, Gary K Koski, et al.
Clinical Immunology (Orlando, Fla.)|July 26, 2002
Immunogenicity and therapeutic efficacy of dendritic-tumor hybrid cells generated by electrofusionTakashi Hayashi, Hiroshi Tanaka, Junta Tanaka, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodesSatoshi Watanabe, Katsuya Deguchi, Rongxiu Zheng, et al.
Clinical Immunology (Orlando, Fla.)|February 12, 2008
Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cellsHidemasa Tamai, Satoshi Watanabe, Rongxiu Zheng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Tumor-induced L-selectinhigh suppressor T cells mediate potent effector T cell blockade and cause failure of otherwise curative adoptive immunotherapyLiaomin Peng, Jørgen Kjaergäard, Gregory E Plautz, et al.
Human Immunology|October 19, 2010
Effect of multiple activation stimuli on the generation of Th1-polarizing dendritic cellsChristopher Paustian, Richard Caspell, Terrence Johnson, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|May 8, 2003
Hybrids of dendritic cells and tumor cells generated by electrofusion simultaneously present immunodominant epitopes from multiple human tumor-associated antigens in the context of MHC class I and class II moleculesMaria R Parkhurst, Cormac DePan, John P Riley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
Memory T cells originate from adoptively transferred effectors and reconstituting host cells after sequential lymphodepletion and adoptive immunotherapyLi-Xin Wang, Jorgen Kjaergaard, Peter A Cohen, et al.
The Laryngoscope|May 3, 2006
Everolimus (RAD) inhibits in vivo growth of murine squamous cell carcinoma (SCC VII)Samir S Khariwala, Jorgen Kjaergaard, Robert Lorenz, et al.
Cancer Metastasis Reviews|June 14, 2006
Immune responses in the draining lymph nodes against cancer: implications for immunotherapySuyu Shu, Alistair J Cochran, Rong-Rong Huang, et al.
Head & Neck|November 13, 2009
Toll-like receptor agonists as third signals for dendritic cell-tumor fusion vaccinesEdward I Cho, Chunrui Tan, Gary K Koski, et al.
Clinical Immunology (Orlando, Fla.)|July 26, 2002
Immunogenicity and therapeutic efficacy of dendritic-tumor hybrid cells generated by electrofusionTakashi Hayashi, Hiroshi Tanaka, Junta Tanaka, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Tumor-induced CD11b+Gr-1+ myeloid cells suppress T cell sensitization in tumor-draining lymph nodesSatoshi Watanabe, Katsuya Deguchi, Rongxiu Zheng, et al.
Clinical Immunology (Orlando, Fla.)|February 12, 2008
Effective treatment of spontaneous metastases derived from a poorly immunogenic murine mammary carcinoma by combined dendritic-tumor hybrid vaccination and adoptive transfer of sensitized T cellsHidemasa Tamai, Satoshi Watanabe, Rongxiu Zheng, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2002
Tumor-induced L-selectinhigh suppressor T cells mediate potent effector T cell blockade and cause failure of otherwise curative adoptive immunotherapyLiaomin Peng, Jørgen Kjaergäard, Gregory E Plautz, et al.
Human Immunology|October 19, 2010
Effect of multiple activation stimuli on the generation of Th1-polarizing dendritic cellsChristopher Paustian, Richard Caspell, Terrence Johnson, et al.
Pageof 4